Review



anti-cd30l antibodies  (Carterra Inc)

 
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 90
      Buy from Supplier

    Structured Review

    Carterra Inc anti-cd30l antibodies
    Anti Cd30l Antibodies, supplied by Carterra Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/anti-cd30l+antibodies/anti+cd30l+antibodies/us11866505-1548-5-15
    Average 90 stars, based on 1 article reviews
    anti-cd30l antibodies - by Bioz Stars, 2026-09
    90/100 stars

    Images

    Related Articles

    Recombinant:

    Article Title: Anti-CD30L antibodies and uses thereof
    Article Snippet: TABLE 9 Characterization of select anti-CD30L antibodies Recombinant KD blocking ELISA Dual cell Clone ID (Carterra) (IC50 nM) assay 62 8.77E−09 5.936 − 63 1.85E−09 3.178 + 64 1.57E−09 3.174 + 65 1.52E−09 3.66 + 66 4.23E−10 12.25 − 67 1.15E−09 12.02 − 68 1.59E−08 3.658 − 69 4.83E−09 3.195 NA 70 2.83E−10 4.192 − 71 2.07E−08 3.576 − 72 4.72E−09 4.045 − 73 7.41E−09 4.791 − 74 3.58E−10 3.712 − 75 3.19E−09 3.394 − 76 5.57E−10 1.669 − 77 4.16E−10 2.716 − 78 3.13E−10 11.76 − 79 8.57E−10 2.023 NA 80 3.54E−09 2.739 ++ 81 1.37E−07 2.763 NA 82 5.59E−10 3.508 + 83 1.94E−10 3.742 − 84 3.23E−10 4.604 − 85 1.22E−08 6.375 − Taking the above Examples (Examples 1-5) together, at leastthree differenthumanized mouse strains have been immunized, multiple independent antibody campaigns have been conducted at different time points, and at least 110 antibodies have been generated and tested.

    Blocking Assay:

    Article Title: Anti-CD30L antibodies and uses thereof
    Article Snippet: TABLE 9 Characterization of select anti-CD30L antibodies Recombinant KD blocking ELISA Dual cell Clone ID (Carterra) (IC50 nM) assay 62 8.77E−09 5.936 − 63 1.85E−09 3.178 + 64 1.57E−09 3.174 + 65 1.52E−09 3.66 + 66 4.23E−10 12.25 − 67 1.15E−09 12.02 − 68 1.59E−08 3.658 − 69 4.83E−09 3.195 NA 70 2.83E−10 4.192 − 71 2.07E−08 3.576 − 72 4.72E−09 4.045 − 73 7.41E−09 4.791 − 74 3.58E−10 3.712 − 75 3.19E−09 3.394 − 76 5.57E−10 1.669 − 77 4.16E−10 2.716 − 78 3.13E−10 11.76 − 79 8.57E−10 2.023 NA 80 3.54E−09 2.739 ++ 81 1.37E−07 2.763 NA 82 5.59E−10 3.508 + 83 1.94E−10 3.742 − 84 3.23E−10 4.604 − 85 1.22E−08 6.375 − Taking the above Examples (Examples 1-5) together, at leastthree differenthumanized mouse strains have been immunized, multiple independent antibody campaigns have been conducted at different time points, and at least 110 antibodies have been generated and tested.

    Enzyme-linked Immunosorbent Assay:

    Article Title: Anti-CD30L antibodies and uses thereof
    Article Snippet: TABLE 9 Characterization of select anti-CD30L antibodies Recombinant KD blocking ELISA Dual cell Clone ID (Carterra) (IC50 nM) assay 62 8.77E−09 5.936 − 63 1.85E−09 3.178 + 64 1.57E−09 3.174 + 65 1.52E−09 3.66 + 66 4.23E−10 12.25 − 67 1.15E−09 12.02 − 68 1.59E−08 3.658 − 69 4.83E−09 3.195 NA 70 2.83E−10 4.192 − 71 2.07E−08 3.576 − 72 4.72E−09 4.045 − 73 7.41E−09 4.791 − 74 3.58E−10 3.712 − 75 3.19E−09 3.394 − 76 5.57E−10 1.669 − 77 4.16E−10 2.716 − 78 3.13E−10 11.76 − 79 8.57E−10 2.023 NA 80 3.54E−09 2.739 ++ 81 1.37E−07 2.763 NA 82 5.59E−10 3.508 + 83 1.94E−10 3.742 − 84 3.23E−10 4.604 − 85 1.22E−08 6.375 − Taking the above Examples (Examples 1-5) together, at leastthree differenthumanized mouse strains have been immunized, multiple independent antibody campaigns have been conducted at different time points, and at least 110 antibodies have been generated and tested.

    Generated:

    Article Title: Anti-CD30L antibodies and uses thereof
    Article Snippet: TABLE 9 Characterization of select anti-CD30L antibodies Recombinant KD blocking ELISA Dual cell Clone ID (Carterra) (IC50 nM) assay 62 8.77E−09 5.936 − 63 1.85E−09 3.178 + 64 1.57E−09 3.174 + 65 1.52E−09 3.66 + 66 4.23E−10 12.25 − 67 1.15E−09 12.02 − 68 1.59E−08 3.658 − 69 4.83E−09 3.195 NA 70 2.83E−10 4.192 − 71 2.07E−08 3.576 − 72 4.72E−09 4.045 − 73 7.41E−09 4.791 − 74 3.58E−10 3.712 − 75 3.19E−09 3.394 − 76 5.57E−10 1.669 − 77 4.16E−10 2.716 − 78 3.13E−10 11.76 − 79 8.57E−10 2.023 NA 80 3.54E−09 2.739 ++ 81 1.37E−07 2.763 NA 82 5.59E−10 3.508 + 83 1.94E−10 3.742 − 84 3.23E−10 4.604 − 85 1.22E−08 6.375 − Taking the above Examples (Examples 1-5) together, at leastthree differenthumanized mouse strains have been immunized, multiple independent antibody campaigns have been conducted at different time points, and at least 110 antibodies have been generated and tested.



    Similar Products

    cd30 l  (Miltenyi Biotec)
    93
    Miltenyi Biotec cd30 l
    Cd30 L, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/anti-cd30l+antibodies/CD153+(CD30L)+Antibody%2C+anti-human%2C+REAfinity/pm39420111-311-3-13
    Average 93 stars, based on 1 article reviews
    cd30 l - by Bioz Stars, 2026-09
    93/100 stars
    		  Buy from Supplier
    anti-cd30l antibodies  (Carterra Inc)
    90
    Carterra Inc anti-cd30l antibodies
    Anti Cd30l Antibodies, supplied by Carterra Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/anti-cd30l+antibodies/anti+cd30l+antibodies/us11866505-1548-5-15
    Average 90 stars, based on 1 article reviews
    anti-cd30l antibodies - by Bioz Stars, 2026-09
    90/100 stars
    		  Buy from Supplier
    cd30l antibody  (Boster Bio)
    90
    Boster Bio cd30l antibody
    Figure 1: The level of CD30 and <t>CD30L</t> in serum from the patients with stable COPD and AECOPD. ((a) and (b)) The level of CD30L and sCD30 in serum from stable COPD and AECOPD and the normal group. Columns, mean of the group; bars, SD. ∗𝑃< 0.05, normal group versus AECOPD group. #𝑃< 0.05, stable COPD group versus AECOPD group.
    Cd30l Antibody, supplied by Boster Bio, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/anti-cd30l+antibodies/Anti-CD30+%2F+TNFRSF8+(Hodgkin+%26+Reed-Sternberg+Cell+Marker)+Monoclonal+Antibody/pm29984229-100-7-11
    Average 90 stars, based on 1 article reviews
    cd30l antibody - by Bioz Stars, 2026-09
    90/100 stars
    		  Buy from Supplier
    anti cd30l antibody  (R&D Systems)
    90
    R&D Systems anti cd30l antibody
    Figure 1: The level of CD30 and <t>CD30L</t> in serum from the patients with stable COPD and AECOPD. ((a) and (b)) The level of CD30L and sCD30 in serum from stable COPD and AECOPD and the normal group. Columns, mean of the group; bars, SD. ∗𝑃< 0.05, normal group versus AECOPD group. #𝑃< 0.05, stable COPD group versus AECOPD group.
    Anti Cd30l Antibody, supplied by R&D Systems, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/anti-cd30l+antibodies/Human+CD30+Ligand%2FTNFSF8+Antibody/pm29431186-177-1-4
    Average 90 stars, based on 1 article reviews
    anti cd30l antibody - by Bioz Stars, 2026-09
    90/100 stars
    		  Buy from Supplier
    goat anti human cd30l primary antibody  (R&D Systems)
    93
    R&D Systems goat anti human cd30l primary antibody
    Figure 1: The level of CD30 and <t>CD30L</t> in serum from the patients with stable COPD and AECOPD. ((a) and (b)) The level of CD30L and sCD30 in serum from stable COPD and AECOPD and the normal group. Columns, mean of the group; bars, SD. ∗𝑃< 0.05, normal group versus AECOPD group. #𝑃< 0.05, stable COPD group versus AECOPD group.
    Goat Anti Human Cd30l Primary Antibody, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/anti-cd30l+antibodies/Human+CD30%2FTNFRSF8+Antibody/pm24447865-67-14-19
    Average 93 stars, based on 1 article reviews
    goat anti human cd30l primary antibody - by Bioz Stars, 2026-09
    93/100 stars
    		  Buy from Supplier
    cd30l with anti cd30lmab  (R&D Systems)
    85
    R&D Systems cd30l with anti cd30lmab
    Figure 1: The level of CD30 and <t>CD30L</t> in serum from the patients with stable COPD and AECOPD. ((a) and (b)) The level of CD30L and sCD30 in serum from stable COPD and AECOPD and the normal group. Columns, mean of the group; bars, SD. ∗𝑃< 0.05, normal group versus AECOPD group. #𝑃< 0.05, stable COPD group versus AECOPD group.
    Cd30l With Anti Cd30lmab, supplied by R&D Systems, used in various techniques. Bioz Stars score: 85/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/anti-cd30l+antibodies/Human+CD30+Ligand%2FTNFSF8+Antibody/pm22628304-42-18-22
    Average 85 stars, based on 1 article reviews
    cd30l with anti cd30lmab - by Bioz Stars, 2026-09
    85/100 stars
    		  Buy from Supplier
    a mouse monoclonal anti-cd30l antibody  (R&D Systems)
    90
    R&D Systems a mouse monoclonal anti-cd30l antibody
    The total number of tryptase-positive mast cells, Kit-positive cells, the percentage of <t> CD30L-positive </t> mast cells and the total number of CD30-positive cells in the upper dermis of the healthy-looking and lesional skin from patients with superficial spreading BCC
    A Mouse Monoclonal Anti Cd30l Antibody, supplied by R&D Systems, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/anti-cd30l+antibodies/mouse+cd30l++22+kda+/pmc11030587-64-2-9
    Average 90 stars, based on 1 article reviews
    a mouse monoclonal anti-cd30l antibody - by Bioz Stars, 2026-09
    90/100 stars
    		  Buy from Supplier

    Image Search Results


    Figure 1: The level of CD30 and CD30L in serum from the patients with stable COPD and AECOPD. ((a) and (b)) The level of CD30L and sCD30 in serum from stable COPD and AECOPD and the normal group. Columns, mean of the group; bars, SD. ∗𝑃< 0.05, normal group versus AECOPD group. #𝑃< 0.05, stable COPD group versus AECOPD group.

    Journal: BioMed research international

    Article Title: CD30 Is Highly Expressed in Chronic Obstructive Pulmonary Disease and Induces the Pulmonary Vascular Remodeling.

    doi: 10.1155/2018/3261436

    Figure Lengend Snippet: Figure 1: The level of CD30 and CD30L in serum from the patients with stable COPD and AECOPD. ((a) and (b)) The level of CD30L and sCD30 in serum from stable COPD and AECOPD and the normal group. Columns, mean of the group; bars, SD. ∗𝑃< 0.05, normal group versus AECOPD group. #𝑃< 0.05, stable COPD group versus AECOPD group.

    Article Snippet: CD30 antibody from Bioss Antibodies (Beijing, China), CD30L antibody purchased from Boster Biological Technology (WuHan, China).

    Techniques:

    Figure 3: Immunohistochemical analysis of CD30, CD30L, MMP-9, and VEGF expression in rat models. (A) The expression levels of CD30, CD30L, MMP-9, and VEGF in lung tissues of rat model groups were determined by IHC. CTR: control group; NTR: negative control group. IHC ×200.

    Journal: BioMed research international

    Article Title: CD30 Is Highly Expressed in Chronic Obstructive Pulmonary Disease and Induces the Pulmonary Vascular Remodeling.

    doi: 10.1155/2018/3261436

    Figure Lengend Snippet: Figure 3: Immunohistochemical analysis of CD30, CD30L, MMP-9, and VEGF expression in rat models. (A) The expression levels of CD30, CD30L, MMP-9, and VEGF in lung tissues of rat model groups were determined by IHC. CTR: control group; NTR: negative control group. IHC ×200.

    Article Snippet: CD30 antibody from Bioss Antibodies (Beijing, China), CD30L antibody purchased from Boster Biological Technology (WuHan, China).

    Techniques: Immunohistochemical staining, Expressing, Control, Negative Control

    The total number of tryptase-positive mast cells, Kit-positive cells, the percentage of CD30L-positive mast cells and the total number of CD30-positive cells in the upper dermis of the healthy-looking and lesional skin from patients with superficial spreading BCC

    Journal: Cancer Immunology, Immunotherapy : CII

    Article Title: Increase in CD30 ligand/CD153 and TNF-α expressing mast cells in basal cell carcinoma

    doi: 10.1007/s00262-007-0290-7

    Figure Lengend Snippet: The total number of tryptase-positive mast cells, Kit-positive cells, the percentage of CD30L-positive mast cells and the total number of CD30-positive cells in the upper dermis of the healthy-looking and lesional skin from patients with superficial spreading BCC

    Article Snippet: Chemicals A mouse monoclonal anti-CD30L antibody was purchased from R&D Systems Europe Ltd (Oxon, UK), and a mouse monoclonal anti-CD30 antibody from Dako (Glostrup, Denmark).

    Techniques: